Christopher Krueger
Fondateur chez Escalier Biosciences BV
Fortune : 1 M $ au 30/04/2024
Profil
Christopher W.
Krueger is the founder of Escalier Biosciences BV, which was founded in 2016.
He is currently the Director at Oppilan Pharma Ltd., Head-Corporate Development at BioCision LLC, Chief Business Officer at Zomagen Biosciences Ltd., and Chief Business Officer at Vimalan Biosciences, Inc. He previously held positions as an Independent Director at CalciMedica, Inc. (US), Counsel at Leidos, Inc., VP-Business Development & Strategic Alliances at Aurora Biosciences Corp., SVP-Business Development & Strategic Alliances at Protemix Corp.
Ltd., Senior Vice President-Business Development at Xencor, Inc., Chief Business Officer at ZP Opco, Inc., Secretary & Chief Business Officer at J.E.M.
Capital, Inc., Attorney at Cooley Godward LLP, Chief Business Officer & Senior Vice President at X-Ceptor Therapeutics, Inc., Secretary, Chief Business Officer & Senior VP at Ardea Biosciences, Inc., Chief Business Officer at Akarna Therapeutics Ltd., and Chief Business Officer at Ventyx Biosciences, Inc. He has a graduate degree and an MBA from the University of Southern California, as well as an undergraduate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VENTYX BIOSCIENCES, INC.
0,48% | 11/04/2024 | 284 999 ( 0,48% ) | 1 M $ | 30/04/2024 |
Postes actifs de Christopher Krueger
| Sociétés | Poste | Début |
|---|---|---|
BioCision LLC
 BioCision LLC Medical SpecialtiesHealth Technology BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA. | Corporate Officer/Principal | - |
Escalier Biosciences BV
 Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands. | Fondateur | 01/12/2016 |
Oppilan Pharma Ltd.
 Oppilan Pharma Ltd. BiotechnologyHealth Technology Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 20/12/2016 |
| Zomagen Biosciences Ltd. | Corporate Officer/Principal | 01/01/2018 |
| Vimalan Biosciences, Inc. | Corporate Officer/Principal | 01/10/2017 |
Anciens postes connus de Christopher Krueger
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Corporate Officer/Principal | 15/04/2024 |
Akarna Therapeutics Ltd.
 Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 01/01/2016 |
| J.E.M. CAPITAL INC | Secrétaire Général | 26/06/2014 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Secrétaire Général | 20/09/2010 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Christopher Krueger
| University of Southern California | Graduate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XENCOR, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Leidos, Inc.
 Leidos, Inc. Information Technology ServicesTechnology Services Leidos, Inc. provides scientific, engineering, systems integration and technical services and solutions. It offers solutions and services that leverage the power of data analytics, systems integration, and cyber security across national security, health, and engineering markets. The company was founded by John Robert Beyster in June 1969 and is headquartered in Reston, VA. | Technology Services |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
Protemix Corp. Ltd.
 Protemix Corp. Ltd. Pharmaceuticals: MajorHealth Technology Protemix Corporation is a biopharmaceutical company that discovers, develops and commercializes novel therapies for the prevention and treatment of cardiovascular disease, diabetes and other metabolic disorders and their complications. Through cost-effective research in New Zealand, the company has assembled a pipeline of novel and innovative compounds, The most advanced compound is in Phase 2b FDA trials for the treatment of diabetic heart failure. Protemix has assembled a pipeline of novel and innovative compounds, the most advanced of which is in Phase 2b FDA trials for the treatment of diabetic heart failure. Protemix’s discovery capabilities capitalize on the 30-year research expertise of the company’s founder, Professor Garth Cooper, a widely recognized expert in the field of peptide hormones, metabolic regulation and diabetes. The company’s discovery efforts are grounded in a detailed understanding of the potential mechanisms underlying diabetes and its complications, and have resulted in a pipeline of drug candidates that intervene at specific, well-defined disease targets to rebalance and renormalize key systems, thus enabling tissue repair and regeneration. Protemix’s lead compound, PX811019, is an orally active molecule that has shown the ability to reverse heart failure based on preclinical diabetic models and significantly reduced left ventricular hypertrophy in human clinic trials. Protemix studies suggest that PX811019 works by rebalancing abnormal copper accumulation in heart muscle, significantly improving cardiac structure and function without lowering blood glucose. The company has received Fast Track status for this compound from the U.S. Food and Drug Administration. The company has a second compound, PX811013, in late preclinical development for the treatment of both alcohol-mediated and non-alcoholic liver damage. The Protemix pipeline also includes six preclinical discovery programs addressing significant market opportunities. Protemix has its commercialization activities and late stage clinical trials driven from San Diego, California with administrative offices in Auckland, New Zealand and research laboratories at the University of Auckland. The company, founded in 1999, is privately held. | Health Technology |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
J.E.M. Capital, Inc.
 J.E.M. Capital, Inc. Financial ConglomeratesFinance J.E.M. Capital, Inc. is a a shell company, which engages in the identification of a privately held operating company which desires to become a publicly held entity by merging with the firm through a reverse merger or acquisition. The company was founded on September 14, 2011 and is headquartered in Hong Kong. | Finance |
BioCision LLC
BioCision LLC Medical SpecialtiesHealth Technology BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA. | Health Technology |
Cooley Godward LLP
 Cooley Godward LLP Miscellaneous Commercial ServicesCommercial Services Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA. | Commercial Services |
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Commercial Services |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
Akarna Therapeutics Ltd.
Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Oppilan Pharma Ltd.
Oppilan Pharma Ltd. BiotechnologyHealth Technology Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands. | Health Technology |
| Zomagen Biosciences Ltd. | |
| Vimalan Biosciences, Inc. |
